Back to Top
Pradusinstobart Biosimilar - Research Grade
$710.00 - $19,500.00
Pradusinstobart Biosimilar - Research Grade
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>95% by SDS-PAGE
Species Reactivity
Human
Target
PD-1
Concentration
5mg/ml
Isotype
Human IgG4 - kappa
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH2957
Uniprot
Q15116
Shipping Conditions
Blue ice
Background
Programmed cell death protein 1 (PD-1) restrains effector T-cell function and remains a primary focus of immune checkpoint research. Supplied as an unconjugated, non-therapeutic analog of pradusinstobart, this research-grade anti-human PD-1 recombinant monoclonal antibody is intended for research use only (RUO). It is manufactured under in vivo quality standards, formulated to be low in endotoxin, and offered in scalable milligram (mg) to gram (g) quantities for heavy-usage, high-throughput laboratories. The reagent supports checkpoint blockade assays, in vitro screening, and in vivo immuno-oncology disease models as a dependable, lot-consistent control and active reagent.
Specificity
Detects human PD-1
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
4 weeks
Write Your Own Review












